Assembly Biosciences, Inc.
ASMB
$34.60
-$1.50-4.16%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 12.08% | 2.20% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.08% | 2.20% | |||
| Cost of Revenue | 2.87% | 8.58% | |||
| Gross Profit | 10.79% | -19.64% | |||
| SG&A Expenses | 10.69% | 1.89% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.60% | 7.02% | |||
| Operating Income | 1.89% | -11.59% | |||
| Income Before Tax | 9.83% | -15.65% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 9.83% | -15.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 9.83% | -15.65% | |||
| EBIT | 1.89% | -11.59% | |||
| EBITDA | 1.90% | -11.64% | |||
| EPS Basic | 45.58% | -13.40% | |||
| Normalized Basic EPS | 45.57% | -13.39% | |||
| EPS Diluted | 45.58% | -13.40% | |||
| Normalized Diluted EPS | 45.57% | -13.39% | |||
| Average Basic Shares Outstanding | 65.70% | 1.99% | |||
| Average Diluted Shares Outstanding | 65.70% | 1.99% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||